Forte Biosciences, Inc. (FBRX)
NASDAQ: FBRX · Real-Time Price · USD
19.34
+0.68 (3.64%)
Dec 20, 2024, 4:00 PM EST - Market closed
Forte Biosciences Market Cap
Forte Biosciences has a market cap or net worth of $28.27 million as of December 20, 2024. Its market cap has increased by 34.19% in one year.
Market Cap
28.27M
Enterprise Value
11.91M
1-Year Change
34.19%
Ranking
Category
Stock Price
$19.34
Market Cap Chart
Since June 16, 2020, Forte Biosciences's market cap has decreased from $181.43M to $28.27M, a decrease of -84.42%. That is a compound annual growth rate of -33.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 28.27M | -5.30% |
| Dec 29, 2023 | 29.86M | 42.17% |
| Dec 30, 2022 | 21.00M | -33.49% |
| Dec 31, 2021 | 31.57M | -93.24% |
| Dec 31, 2020 | 467.16M | 157.48% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| RAPT Therapeutics | 28.24M |
| CytoMed Therapeutics | 28.16M |
| Calidi Biotherapeutics | 28.01M |
| KALA BIO | 27.66M |
| RenovoRx | 27.58M |
| Adagio Medical Holdings | 26.74M |
| DURECT | 26.63M |
| NextCure | 26.61M |